A podcast focusing on biotechnology and its promise to transform the lives of people living around the world with rare and serious diseases.
During each episode, we explore a topic related to biotechnology and rare disease by interviewing doctors, scientists, patients, family members of people with rare or serious diseases, and or other experts in biotechnology. The show both highlights the exciting world of biotechnology and the impact it is having on patients while also offering advice and insights for people who have rare or serious diseases as well as their family members or caregivers.
Listen: The Future of Flu Vaccines
On a new episode of World of Promise, host Anthony Farina is joined by Stefan Merlo, Vice President of Commercial Development at Seqirus, and Roberta Duncan, the vaccine company's Vice President, mRNA Program Lead, to discuss what’s next in terms of flu vaccine technology. They discuss the potential of aQIVc flu vaccine technology as well as sa-mRNA and how it differs from other mRNA vaccines.
The Importance of Pandemic Preparedness
COVID-19 has offered the biotech industry many lessons. Among the lessons that stands out to Lorna Meldrum is the importance of being prepared for both seasonal flu and the potential for a pandemic outbreak. Meldrum is Vice President of Commercial Operations, International Markets and Pandemic at Seqirus, one of the world’s leading influenza vaccine producers.
The Safety of Vaccines
Amidst the development and rollout of COVID-19 vaccines around the globe, conversations around vaccine safety are at an all-time high. On this episode, Gregg Sylvester, Chief Medical Officer and Head of Medical Affairs for leading vaccine producer Seqirus, sits down with host Anthony Farina to discuss how Seqirus ensures that its vaccines are safe – the processes that are implemented and why this topic is so important to an organization on the front lines to protect public health.
How Technology is Changing Vaccines
Innovation was key to creating effective vaccines in the fight against COVID-19. Now, those innovations are being studied for the creation of leading edge influenza vaccines, explains Ethan Settembre, VP, R&D for Seqirus. He talks about how Seqirus is leveraging existing cell and adjuvant technology to deliver effective vaccines and exploring the combination of the two in aQIVc, the company’s next pipeline vaccine.
Adapting to Change: World Hemophilia Day 2021
The theme for this year’s World Hemophilia Day on April 17 is “Adapting to Change.” The day raises awareness for hemophilia and other bleeding disorders. This episode features Dr. Glenn Pierce, Vice President, Medical, for the World Federation of Hemophilia and Dr. Roshni Kulkarni, professor and former Director of Michigan State University’s Center for Bleeding and Clotting Disorders. They talk about changes in hemophilia and bleeding disorder treatments and how this past year has changed everythi
Taking Risks, Overcoming Doubts: Two Top Biotech Leaders Share Their Experiences and Offer Career Advice in Honor of Women's History Month
In honor of Women's History Month, this episode features two CSL leaders. Karen Neave, Senior Vice President and Chief Risk Officer, and Antje Michel, General Counsel, share their career journeys, the obstacles they've overcome and offer advice for other women working in biotechnology. During the 20-minute conversation, they also offer insights into how they achieved success and work/life balance, particularly in today’s COVID-19 remote working environment.